Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
946 participants
OBSERVATIONAL
2013-08-31
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Participants were recruited using several non-probability sampling techniques, (including purposive sampling and snowball sampling), because random sampling is not possible with this population. Medical, social, support, and advocacy networks used by trans people were used to promote the study. A mixed quantitative and qualitative methodology was used. Validated quantitative instruments were used to obtain measures of health and well-being, which will be compared against population norms. Qualitative items complement these measures, providing rich experiential data.
The investigators hypothesised that:
* the prevalence of depressive and anxiety disorders will be higher than for the population generally, and that these conditions will commonly be undiagnosed and untreated;
* depressive and anxiety disorders will be associated with risky behaviours, such as tobacco, alcohol, and illicit drug use; and,
* trans people will report poor relationships with medical practitioners.
The investigators hypothesised that poor mental health is a consequence of several interrelated factors: body dysphoria (as a consequence of experiencing difficulty accessing medical treatment to alter sexual characteristics); societal discrimination and stigma (including harassment and violence); institutionalised discrimination (including difficulty changing identifying documents, and exclusion of surgical procedures and related treatments from public and private health systems); social isolation; and the belief held by many clinicians that transsexualism is a mental disorder (which may be a barrier to trans people forming trusting relationships with medical practitioners).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Psychotherapy Trial With Transgender Clients
NCT03369054
The Elite Athlete Mental Health Strategy Trial
NCT00940732
Improving Student Mental Health: Adaptive School-based Implementation of CBT
NCT03541317
Testing the Effectiveness of Adolescent Depression Prevention Programs (The OregonBlues Study)
NCT00904891
Internet-delivered Treatment for Transgender Individuals With Co-occurring Mental Health Problems
NCT05534763
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Transgender and Transsexual People
Transgender and transsexual (trans) people aged 18 years or older living in Australia were invited to complete a questionnaire assessing a range of mental and physical health domains.
questionnaire
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
questionnaire
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Self-identify as trans
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beyondblue (The National Depression Initiative)
OTHER
Curtin University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zoë Hyde
Dr
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zoë Hyde, MPH PhD
Role: PRINCIPAL_INVESTIGATOR
Curtin University
Maryanne Doherty, MSc PhD
Role: PRINCIPAL_INVESTIGATOR
Curtin University
Peter Tilley, MPsych
Role: PRINCIPAL_INVESTIGATOR
Curtin University
Kieran A. McCaul, MPH PhD
Role: PRINCIPAL_INVESTIGATOR
The University of Western Australia
Rosanna Rooney, MPsych PhD
Role: PRINCIPAL_INVESTIGATOR
Curtin University
Jonine Jancey, PhD
Role: PRINCIPAL_INVESTIGATOR
Curtin University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Curtin University
Perth, Western Australia, Australia
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Study website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CB:gc:6722
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.